FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000712602> ?p ?o ?g. }

• W2000712602 endingPage "80" @default.
• W2000712602 startingPage "77" @default.
• W2000712602 abstract "A phase II study was conducted to evaluate the efficacy and toxicity of vinorelbine-carboplatin (VNB-C) combination as a salvage treatment in patients with advanced non-small cell lung cancer (NSCLC) progressing after or failing previous non-platinum, taxane-based treatment.Thirty-seven patients with cytologically or histologically confirmed NSCLC were enrolled. VNB 30 mg/m(2) was administered on days 1 and 8 and C 300 mg/m(2) on day 1 every 28 days. G-CSF (5 microg/kg per day s.c.) was used prophylactically on days 10-15 in case of grade 3-4 neutropenia or febrile neutropenia after the first cycle.Twenty-nine patients were evaluable for response and all were evaluable for toxicity. In an intention-to-treat analysis, two (5%) complete and four (11%) partial responses were documented for an overall response rate of 16% (95% CI, 4.49-28.84%). Eleven (30%) patients experienced disease stabilisation and 20 (54%) disease progression. The median duration of response was 7.5 months, the median TTP was 9 months, and the median survival was 8.5 months. Patients with objective remission and stable disease had a statistically significant survival benefit over patients with disease progression. Grade 3 and 4 neutropenia occurred in three (8%) and ten (27%) patients, respectively, and six cases (16%) were complicated with fever. Grade 4 thrombocytopenia was documented in one (3%) patient. Non-hematological toxicity was mild, with grade 2 and 3 asthenia reported in 18 (48%) patients. No treatment-related deaths occurred.VNB-C combination is well tolerated and retains a notable degree of activity in NSCLC patients progressing after previous non-platinum, taxane-based treatment. Moreover, it confers tumour growth control in a significant proportion of patients, and this seems to be associated with a survival benefit for them." @default.
• W2000712602 created "2016-06-24" @default.
• W2000712602 creator A5001430197 @default.
• W2000712602 creator A5008406543 @default.
• W2000712602 creator A5021298053 @default.
• W2000712602 creator A5021554009 @default.
• W2000712602 creator A5038933654 @default.
• W2000712602 creator A5046050577 @default.
• W2000712602 creator A5060929404 @default.
• W2000712602 creator A5067037165 @default.
• W2000712602 creator A5072200464 @default.
• W2000712602 creator A5078192662 @default.
• W2000712602 creator A5084377238 @default.
• W2000712602 date "2001-12-01" @default.
• W2000712602 modified "2023-09-23" @default.
• W2000712602 title "Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study" @default.
• W2000712602 cites W1883066466 @default.
• W2000712602 cites W1934698255 @default.
• W2000712602 cites W1979300931 @default.
• W2000712602 cites W1993310964 @default.
• W2000712602 cites W2103322036 @default.
• W2000712602 cites W2130652363 @default.
• W2000712602 cites W2141517959 @default.
• W2000712602 cites W2167805334 @default.
• W2000712602 cites W2331645273 @default.
• W2000712602 cites W2413834130 @default.
• W2000712602 cites W2419257766 @default.
• W2000712602 cites W2440265926 @default.
• W2000712602 cites W2474438615 @default.
• W2000712602 cites W75871244 @default.
• W2000712602 doi "https://doi.org/10.1016/s0169-5002(01)00387-7" @default.
• W2000712602 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11742708" @default.
• W2000712602 hasPublicationYear "2001" @default.
• W2000712602 type Work @default.
• W2000712602 sameAs 2000712602 @default.
• W2000712602 citedByCount "12" @default.
• W2000712602 crossrefType "journal-article" @default.
• W2000712602 hasAuthorship W2000712602A5001430197 @default.
• W2000712602 hasAuthorship W2000712602A5008406543 @default.
• W2000712602 hasAuthorship W2000712602A5021298053 @default.
• W2000712602 hasAuthorship W2000712602A5021554009 @default.
• W2000712602 hasAuthorship W2000712602A5038933654 @default.
• W2000712602 hasAuthorship W2000712602A5046050577 @default.
• W2000712602 hasAuthorship W2000712602A5060929404 @default.
• W2000712602 hasAuthorship W2000712602A5067037165 @default.
• W2000712602 hasAuthorship W2000712602A5072200464 @default.
• W2000712602 hasAuthorship W2000712602A5078192662 @default.
• W2000712602 hasAuthorship W2000712602A5084377238 @default.
• W2000712602 hasConcept C121608353 @default.
• W2000712602 hasConcept C126322002 @default.
• W2000712602 hasConcept C141071460 @default.
• W2000712602 hasConcept C2776256026 @default.
• W2000712602 hasConcept C2776694085 @default.
• W2000712602 hasConcept C2777063308 @default.
• W2000712602 hasConcept C2777511904 @default.
• W2000712602 hasConcept C2778239845 @default.
• W2000712602 hasConcept C2778822529 @default.
• W2000712602 hasConcept C2778850193 @default.
• W2000712602 hasConcept C2780350996 @default.
• W2000712602 hasConcept C2781451048 @default.
• W2000712602 hasConcept C29730261 @default.
• W2000712602 hasConcept C31760486 @default.
• W2000712602 hasConcept C530470458 @default.
• W2000712602 hasConcept C71924100 @default.
• W2000712602 hasConcept C90924648 @default.
• W2000712602 hasConceptScore W2000712602C121608353 @default.
• W2000712602 hasConceptScore W2000712602C126322002 @default.
• W2000712602 hasConceptScore W2000712602C141071460 @default.
• W2000712602 hasConceptScore W2000712602C2776256026 @default.
• W2000712602 hasConceptScore W2000712602C2776694085 @default.
• W2000712602 hasConceptScore W2000712602C2777063308 @default.
• W2000712602 hasConceptScore W2000712602C2777511904 @default.
• W2000712602 hasConceptScore W2000712602C2778239845 @default.
• W2000712602 hasConceptScore W2000712602C2778822529 @default.
• W2000712602 hasConceptScore W2000712602C2778850193 @default.
• W2000712602 hasConceptScore W2000712602C2780350996 @default.
• W2000712602 hasConceptScore W2000712602C2781451048 @default.
• W2000712602 hasConceptScore W2000712602C29730261 @default.
• W2000712602 hasConceptScore W2000712602C31760486 @default.
• W2000712602 hasConceptScore W2000712602C530470458 @default.
• W2000712602 hasConceptScore W2000712602C71924100 @default.
• W2000712602 hasConceptScore W2000712602C90924648 @default.
• W2000712602 hasLocation W20007126021 @default.
• W2000712602 hasLocation W20007126022 @default.
• W2000712602 hasOpenAccess W2000712602 @default.
• W2000712602 hasPrimaryLocation W20007126021 @default.
• W2000712602 hasRelatedWork W1975832547 @default.
• W2000712602 hasRelatedWork W1991613108 @default.
• W2000712602 hasRelatedWork W2000712602 @default.
• W2000712602 hasRelatedWork W2031688088 @default.
• W2000712602 hasRelatedWork W2086499508 @default.
• W2000712602 hasRelatedWork W2151150722 @default.
• W2000712602 hasRelatedWork W2170179169 @default.
• W2000712602 hasRelatedWork W2182539523 @default.
• W2000712602 hasRelatedWork W2183888492 @default.
• W2000712602 hasRelatedWork W2188072063 @default.
• W2000712602 hasVolume "34" @default.
• W2000712602 isParatext "false" @default.

• next